|
QKI expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.25000018616583E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.1273999469621E-09 |
| Normal-vs-Stage2 |
5.97519999999685E-05 |
| Normal-vs-Stage3 |
1.48229983842896E-10 |
| Normal-vs-Stage4 |
1.66444635851803E-12 |
| Stage1-vs-Stage2 |
6.120600E-01 |
| Stage1-vs-Stage3 |
9.357900E-02 |
| Stage1-vs-Stage4 |
9.85199999999908E-05 |
| Stage2-vs-Stage3 |
1.062450E-01 |
| Stage2-vs-Stage4 |
2.157400E-03 |
| Stage3-vs-Stage4 |
4.627800E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.35640404358628E-11 |
| Normal-vs-AfricanAmerican |
1.55238999999252E-05 |
| Normal-vs-Asian |
5.04799999578864E-08 |
| Caucasian-vs-AfricanAmerican |
8.974200E-01 |
| Caucasian-vs-Asian |
8.868800E-01 |
| AfricanAmerican-vs-Asian |
9.821400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.84499999722476E-08 |
| Normal-vs-Female |
1.71730407672044E-11 |
| Male-vs-Female |
7.996600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.03490000014084E-07 |
| Normal-vs-Age(41-60Yrs) |
3.26869642464089E-11 |
| Normal-vs-Age(61-80Yrs) |
2.59069987684768E-10 |
| Normal-vs-Age(81-100Yrs) |
1.583540E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.786440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.856410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.146800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.252200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.896200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.509400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.403200E-03 |
| Classical-VS-Follicular |
8.997600E-01 |
| Classical-VS-Other |
3.885400E-01 |
| Classical-VS-Normal |
1.03649999694255E-09 |
| Tall-VS-Follicular |
1.526240E-02 |
| Tall-VS-Other |
5.673800E-01 |
| Tall-VS-Normal |
8.71310024130878E-10 |
| Follicular-VS-Other |
4.172200E-01 |
| Follicular-VS-Normal |
1.11039999994844E-06 |
| Other-VS-Normal |
1.357480E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.59830001958505E-09 |
| Normal-vs-N1 |
6.71118716155661E-12 |
| N0-vs-N1 |
2.457900E-02 |
|
|
